Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Bushen Xiezhuo Fang is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of hyperuricemia and gout. The formula is designed based on the TCM principles of strengthening the spleen (Jianpi), tonifying the kidney (Bushen), and discharging turbidity (Xiezhuo) to regulate uric acid metabolism. It is typically administered as a decoction or granules. Clinical research, such as trials conducted by the Chongqing Hospital of Traditional Chinese Medicine, evaluates its efficacy in lowering serum uric acid levels and preventing gout flares, often comparing it to conventional urate-lowering therapies like febuxostat and benzbromarone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Bushen Xiezhuo Fang.